Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Global Pharmaceuticals Corp.

Division of Amneal Pharmaceuticals LLC
www.globalphar.com

Latest From Global Pharmaceuticals Corp.

US Subpoena For Sun Amid Pricing Heat

US lawmakers continue to scrutinize drug firms amid ongoing concerns over price-related issues and their impact on healthcare costs. The US Justice Department’s antitrust division has now subpoenaed Sun Pharma for information pertaining to generic drugs, pricing and certain company records, though the Indian firm claimed the move would have no immediate impact on its earnings.

BioPharmaceutical India

Indian Firms Blame U.S. Price Hikes On Compliance Costs

Put simply, Indian generic firms’ take on why the prices of some of their products have surged in the United States is down to strict inspections and the costs of compliance. Dr Reddy's Laboratories has clarified that it doesn't even market one of the products in question.

BioPharmaceutical India

Deals Shaping The Medical Industry, October 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, September 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Amneal Pharmaceuticals LLC
  • Senior Management
  • Carole S Ben-Maimon, Pres.
    David Berman, VP, Bus. Dev.
    Richard Ting, SVP, Generic R&D
    Todd Engle, Sr. Dir., Mktg. & Sales
  • Contact Info
  • Global Pharmaceuticals Corp.
    Phone: (215) 558-4300
    121 New Britain Blvd.
    Chalfont, PA 18914
    USA
UsernamePublicRestriction

Register